Switching from an NPH Insulin to an Insulin Glargine Basal-Bolus Regimen Improves Glycemic Control in Diabetic Patients: The LINDA Study

被引：0
|
作者：
Kvapil, Milan
Krivska, Bohumila
Avy, Zdenek Ru
机构：
来源：
DIABETES | 2011年 / 60卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2335-PO
引用
收藏
页码：A621 / A621
页数：1
相关论文
共 50 条
  • [31] PATIENT TREATMENT SATISFACTION OF TYPE 2 DIABETIC PATIENTS TREATED WITH A BASAL-BOLUS REGIMEN USING INSULINS GLARGINE OR DETEMIR AS BASAL INSULIN: RESULTS FROM THE LIVE-COM STUDY
    Moock, J.
    Hessel, F.
    Kohlmann, T.
    VALUE IN HEALTH, 2009, 12 (07) : A411 - A411
  • [32] Introduction of insulin glargine to basal-bolus therapy improves metabolic control in patients with type 2 diabetes in everyday clinical practice
    Ruhnau, KJ
    Schneider, K
    Schweitzer, MA
    DIABETES, 2005, 54 : A518 - A518
  • [33] Introduction of insulin glargine to basal-bolus therapy improves metabolic control in patients with type 1 diabetes in everyday clinical practice
    Donaubauer, B
    Schneider, K
    Schweitzer, MA
    DIABETOLOGIA, 2005, 48 : A329 - A329
  • [34] Introduction of insulin glargine to basal-bolus therapy improves metabolic control in patients with type 2 diabetes in everyday clinical practice
    Ruhnau, KJ
    Schneider, K
    Schweitzer, MA
    DIABETOLOGIA, 2005, 48 : A303 - A303
  • [35] The basal to total insulin ratio in outpatients with diabetes on basal-bolus regimen
    Castellano E.
    Attanasio R.
    Giagulli V.A.
    Boriano A.
    Terzolo M.
    Papini E.
    Guastamacchia E.
    Monti S.
    Aglialoro A.
    Agrimi D.
    Ansaldi E.
    Babini A.C.
    Blatto A.
    Brancato D.
    Casile C.
    Cassibba S.
    Crescenti C.
    De Feo M.L.
    Del Prete A.
    Disoteo O.
    Ermetici F.
    Fiore V.
    Fusco A.
    Gioia D.
    Grassi A.
    Gullo D.
    Lo Pomo F.
    Miceli A.
    Nizzoli M.
    Pellegrino M.
    Pirali B.
    Santini C.
    Settembrini S.
    Tortato E.
    Triggiani V.
    Vacirca A.
    Borretta G.
    Journal of Diabetes & Metabolic Disorders, 2018, 17 (2): : 393 - 399
  • [36] Insulin detemir improves glycemic control with reduced risk of hypoglycemia and weight loss in patients previously treated with insulin glargine or NPH insulin
    Meneghini, Luigi
    Koenen, Christoph
    Rojas, Patrick
    Selam, Jean-Louis
    DIABETES, 2007, 56 : A573 - A573
  • [37] Glycaemic control with insulin glulisine versus regular human insulin in a basal-bolus regimen in patients with Type 2 diabetes
    Dailey, G
    Rosenstock, J
    Moses, R
    Ways, K
    DIABETOLOGIA, 2004, 47 : A265 - A266
  • [38] COST-EFFECTIVENESS OF INSULIN DEGLUDEC COMPARED WITH INSULIN GLARGINE IN A BASAL-BOLUS REGIMEN IN PATIENTS WITH TYPE 1 DIABETES MELLITUS IN THE UNITED KINGDOM
    Chubb, B.
    Evans, M.
    Wolden, M.
    Christensen, T.
    Gundgaard, J.
    VALUE IN HEALTH, 2013, 16 (07) : A442 - A442
  • [39] Insulin dose and weight profiles of pre- and post-meal insulin glulisine in a basal-bolus regimen with insulin glargine in patients with Type 1 diabetes
    Klaff, L
    Rosenstock, J
    Garg, S
    Souhami, E
    Ways, K
    DIABETOLOGIA, 2004, 47 : A300 - A300
  • [40] Glucotab-Based Basal-Bolus Insulin Therapy for Inpatient Glycemic Control Using Insulin Degludec
    Mader, Julia K.
    Baumann, Petra M.
    Aberer, Felix
    Hochfellner, Daniel A.
    Simic, Amra
    Bytyqi, Lirie
    Poettler, Tina
    Hoell, Bernhard
    Fahrleitner-Pammer, Astrid
    Pieber, Thomas
    Beck, Peter
    DIABETES, 2021, 70
12345